Cargando…

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer

Breast cancer (BC) is one of the most common cancers in women worldwide. Even though the role of estrogen receptor alpha (ERα) is extensively documented in the development of breast tumors, other members of the nuclear receptor family have emerged as important players. Synthetic glucocorticoids (GCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noureddine, Lara Malik, Trédan, Olivier, Hussein, Nader, Badran, Bassam, Le Romancer, Muriel, Poulard, Coralie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123001/ https://www.ncbi.nlm.nih.gov/pubmed/33923160 http://dx.doi.org/10.3390/ijms22094446

Ejemplares similares

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023)

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
por: Mery, Benoîte, et al.
Publicado: (2021)

Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a
por: Poulard, Coralie, et al.
Publicado: (2021)

ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020)

JMJD6 Regulates ERα Methylation on Arginine
por: Poulard, Coralie, et al.
Publicado: (2014)

Activation of rapid oestrogen signalling in aggressive human breast cancers
por: Poulard, Coralie, et al.
Publicado: (2012)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Role of JMJD6 in Breast Tumourigenesis
por: Poulard, Coralie, et al.
Publicado: (2015)

PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer
por: Malbeteau, Lucie, et al.
Publicado: (2022)

PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019)

Protein arginine methylation/demethylation and cancer
por: Poulard, Coralie, et al.
Publicado: (2016)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα (+) breast cancer
por: Poulard, Coralie, et al.
Publicado: (2023)

Structure, Activity, and Function of PRMT1
por: Thiebaut, Charlène, et al.
Publicado: (2021)

How Protein Methylation Regulates Steroid Receptor Function
por: Malbeteau, Lucie, et al.
Publicado: (2021)

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020)

A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction
por: El Sabeh, Rana, et al.
Publicado: (2021)

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
por: Choucair, Ali, et al.
Publicado: (2019)

Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation
por: Farhat, Diana, et al.
Publicado: (2020)

‘One Health’ Actors in Multifaceted Health Systems: An Operational Case for India
por: Yasobant, Sandul, et al.
Publicado: (2020)

Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
por: Jacquemetton, Julien, et al.
Publicado: (2021)

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
por: Sommariva, Michele, et al.
Publicado: (2020)

Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer
por: Eve, Louisane, et al.
Publicado: (2020)

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)

The glucocorticoid receptor signalling in breast cancer
por: Moutsatsou, Paraskevi, et al.
Publicado: (2008)

RAS as Supporting Actor in Breast Cancer
por: Galiè, Mirco
Publicado: (2019)

Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation
por: Redmond, Aisling M., et al.
Publicado: (2019)

The Multifaceted Melanocortin Receptors
por: Laiho, Linda, et al.
Publicado: (2022)

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017)

Juegos para actores y no actores /
por: Boal, Augusto
Publicado: (2002)

Confesiones de un actor /
por: Olivier, Laurence, 1907-1989
Publicado: (1984)

The scaffold protein menin is essential for activating the MYC locus and MYC‐mediated androgen receptor transcription in androgen receptor‐dependent prostate cancer cells
por: Luo, Yakun, et al.
Publicado: (2021)

Expression of the glucocorticoid receptor in breast cancer-associated fibroblasts
por: Catteau, Xavier, et al.
Publicado: (2016)

Glucocorticoid receptor signalling activates YAP in breast cancer
por: Sorrentino, Giovanni, et al.
Publicado: (2017)

Discoidin Domain Receptors: Potential Actors and Targets in Cancer
por: Rammal, Hassan, et al.
Publicado: (2016)

Actores sociales, actores locales : algunas hipótesis de trabajo
por: Lorenzo Río, María Dolores
Publicado: (2012)

Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death
por: Poulard, Coralie, et al.
Publicado: (2018)

Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases
por: Porter, Baylee A., et al.
Publicado: (2023)

The Multifaceted Role of Regulatory T Cells in Breast Cancer
por: Kos, Kevin, et al.
Publicado: (2021)

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer
por: Gandhi, Shipra, et al.
Publicado: (2020)

Chemokine receptors: multifaceted therapeutic targets
por: Proudfoot, Amanda E. I.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_1a6007f7nee9n6tvkjb867pift